STRATEGIES FOR THE TREATMENT AND MANAGEMENT OF HYPERTENSION BASED ON AN INDIVIDUALIZED APPROACH

Abdurakhmanov Azizbek Batirovich

Assistant of the Department of Internal Diseases and Endocrinology, Urgench Branch of Tashkent Medical Academy

Zaripov Sirojiddin Bayjanbaevich

Assistant of the Department of Internal Diseases and Endocrinology, Urgench Branch of Tashkent Medical Academy

Kodirbergenov Tangribergan Bakhodirovich

Assistant of the Department of Internal Diseases and Endocrinology, Urgench Branch of Tashkent Medical Academy

Keywords: Hypertension, individualized treatment, personalized medicine, blood pressure control, cardiovascular risk, lifestyle modification, pharmacological therapy, patient monitoring, comorbidities, therapeutic adherence, clinical guidelines.


Abstract

This article explores individualized strategies for the treatment and management of hypertension. Given the complex and multifactorial nature of hypertension, a one-size-fits-all approach is often insufficient. The paper highlights the importance of personalized care based on a patient's age, genetic background, lifestyle, comorbidities, and response to therapy. It discusses modern diagnostic tools and treatment modalities that support tailored interventions. Emphasis is placed on continuous monitoring, patient education, and adherence to therapeutic plans to achieve optimal blood pressure control and reduce cardiovascular risks.


References

1. Whelton, P. K., et al. (2018). 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Journal of the American College of Cardiology, 71(19), e127–e248.

2. Carey, R. M., & Whelton, P. K. (2020). Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Hypertension, 75(1), 14–30.

3. Williams, B., et al. (2018). 2018 ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal, 39(33), 3021–3104.

4. Oparil, S., et al. (2018). Hypertension: Pathogenesis, Diagnosis, and Therapy. New England Journal of Medicine, 378(7), 636–644.

5. Mills, K. T., et al. (2016). Global disparities of hypertension prevalence and control. Circulation, 134(6), 441–450.

6. Kjeldsen, S. E. (2018). Hypertension and cardiovascular risk: General aspects. Pharmacological Research, 129, 95–99.

7. Padwal, R., et al. (2019). Clinical utility of home blood pressure monitoring in hypertension diagnosis and treatment. Canadian Family Physician, 65(3), 186–190.

8. Burnier, M., & Egan, B. M. (2019). Adherence in hypertension. Circulation Research, 124(7), 1124–1140.

9. Pimenta, E., & Calhoun, D. A. (2012). Resistant hypertension: Incidence, prevalence, and prognosis. Circulation, 125(13), 1594–1596.

10. James, P. A., et al. (2014). 2014 Evidence-based guideline for the management of high blood pressure in adults. JAMA, 311(5), 507–520.

11. Mancia, G., et al. (2013). The role of combination therapy in the management of hypertension. European Heart Journal Supplements, 15(Suppl B), B17–B24.

12. Brook, R. D., et al. (2010). Beyond medications and diet: Lifestyle changes to lower blood pressure. Journal of Clinical Hypertension, 12(9), 609–616.

13. Flack, J. M., et al. (2010). Management of high blood pressure in blacks: An update of the International Society on Hypertension in Blacks consensus statement. Hypertension, 56(5), 780–800.

14. Chobanian, A. V. (2009). Clinical practice. Isolated systolic hypertension in the elderly. New England Journal of Medicine, 357(8), 789–796.

15. Zanchetti, A., et al. (2015). Individualized treatment targets for hypertension. Current Hypertension Reports, 17(2), 14.

16. Weber, M. A., et al. (2014). Clinical practice guidelines for the management of hypertension in the community. Journal of Clinical Hypertension, 16(1), 14–26.